Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Chubb
Colorcon
Citi
Chinese Patent Office
Express Scripts
Cipla
Queensland Health
Baxter
McKesson

Generated: August 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 086961

« Back to Dashboard
NDA 086961 describes HYDRALAZINE HYDROCHLORIDE, which is a drug marketed by Hetero Labs Ltd Iii, Watson Labs, Mutual Pharm, Vangard, X-gen Pharms Inc, Ascot, Mylan, Solopak, Smith And Nephew, Halsey, Impax Labs, Glenmark Pharms Ltd, Frontida Biopharm, Akorn, Abraxis Pharm, Luitpold, Par Pharm, Sciegen Pharms Inc, Alkem Labs Ltd, Ivax Sub Teva Pharms, Navinta Llc, West Ward, Upsher-smith Labs, Heritage Pharms Inc, Cadila Pharms Ltd, Tg United Labs, Actavis Elizabeth, Usl Pharma, Quantum Pharmics, Invagen Pharms, Pliva, Strides Pharma, Teva Parenteral, Purepac Pharm, Actavis Grp Ptc, Mylan Institutional, Superpharm, Fresenius Kabi Usa, Sandoz, Vitarine, Solvay, and Ivax Pharms, and is included in ninety-one NDAs. It is available from forty-two suppliers. Additional details are available on the HYDRALAZINE HYDROCHLORIDE profile page.

The generic ingredient in HYDRALAZINE HYDROCHLORIDE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.

Summary for NDA: 086961

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 086961

Physiological EffectArteriolar Vasodilation

Suppliers and Packaging for NDA: 086961

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HYDRALAZINE HYDROCHLORIDE
hydralazine hydrochloride
TABLET;ORAL 086961 ANDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-0531 0615-0531-05 15 TABLET in 1 BLISTER PACK (0615-0531-05)
HYDRALAZINE HYDROCHLORIDE
hydralazine hydrochloride
TABLET;ORAL 086961 ANDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-0531 0615-0531-39 30 TABLET in 1 BLISTER PACK (0615-0531-39)

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Approved Prior to Jan 1, 1982TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Chinese Patent Office
Colorcon
Fish and Richardson
UBS
Dow
Cantor Fitzgerald
Cipla
Chubb
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot